ResearcherUniversity of MichiganActive in the last 2 years
Seema Chugh
Matched on ORCID iD 0000-0003-1486-0725; OpenAlex author ID A5036384868. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 52
2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 2 papers · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 12
- GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2026.117314↗
- Integrative genomic identification of therapeutic targets for pancreatic cancer. Co-author DOI 10.1016/j.celrep.2025.116191↗
- Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-24-0177↗
- Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. Co-author DOI 10.1038/s41388-021-02047-2↗
- Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-020-01518-2↗
- Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41416-020-0772-3↗
- An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development. Co-author DOI 10.1038/s41467-020-16309-2↗
- Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. Co-author DOI 10.1053/j.gastro.2018.05.041↗
- Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. First author DOI 10.1186/s12885-018-5074-2↗
- Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation. Co-author DOI 10.1038/bjc.2016.116↗
- MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism. Co-author DOI 10.18632/genesandcancer.104↗
- Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Co-author DOI 10.1016/j.addr.2014.10.020↗
Closest collaborators
The 25 strongest of 52 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Moorthy Palanimuthu Ponnusamy · 7 shared papers, 2016–2022 · strength 0.63
- Paper Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. DOI 10.1038/s41388-021-02047-2↗
- Paper Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. DOI 10.1038/s41416-020-0772-3↗
- Paper Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-020-01518-2↗
- Satyanarayana Rachagani · 7 shared papers, 2015–2022 · strength 0.61
- Paper Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. DOI 10.1038/s41388-021-02047-2↗
- Paper Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. DOI 10.1038/s41416-020-0772-3↗
- Paper Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-020-01518-2↗
- Surinder K. Batra · 7 shared papers, 2015–2022 · strength 0.58
- Paper Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. DOI 10.1038/s41388-021-02047-2↗
- Paper Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-020-01518-2↗
- Paper Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. DOI 10.1186/s12885-018-5074-2↗
- Rama Krishna Nimmakayala · 4 shared papers, 2018–2022 · strength 0.41
- Paper Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. DOI 10.1038/s41388-021-02047-2↗
- Paper Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. DOI 10.1038/s41416-020-0772-3↗
- Paper Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-020-01518-2↗
- William L. Hwang · 2 shared papers, 2025–2026 · strength 0.41
- Dennis H. Gong · 2 shared papers, 2025–2026 · strength 0.41
- Julien Dilly · 2 shared papers, 2025–2026 · strength 0.41
- Carina Shiau · 2 shared papers, 2025–2026 · strength 0.41
- Jimmy A. Guo · 2 shared papers, 2025–2026 · strength 0.41
- Andrew J. Aguirre · 2 shared papers, 2025–2026 · strength 0.41
- Saswati Karmakar · 4 shared papers, 2018–2022 · strength 0.40
- Paper Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. DOI 10.1038/s41388-021-02047-2↗
- Paper Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. DOI 10.1038/s41416-020-0772-3↗
- Paper Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. DOI 10.1186/s12885-018-5074-2↗
- Frank Leon · 3 shared papers, 2020–2022 · strength 0.35
- Paper Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. DOI 10.1038/s41388-021-02047-2↗
- Paper Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. DOI 10.1038/s41416-020-0772-3↗
- Paper Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-020-01518-2↗
- Palanisamy Nallasamy · 3 shared papers, 2020–2022 · strength 0.35
- Paper Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. DOI 10.1038/s41388-021-02047-2↗
- Paper Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. DOI 10.1038/s41416-020-0772-3↗
- Paper Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-020-01518-2↗
- Parthasarathy Seshacharyulu · 4 shared papers, 2015–2022 · strength 0.32
- Paper Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. DOI 10.1038/s41388-021-02047-2↗
- Paper Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. DOI 10.1053/j.gastro.2018.05.041↗
- Paper MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mecha… DOI 10.18632/genesandcancer.104↗
- Sanchita Rauth · 3 shared papers, 2018–2021 · strength 0.25
- Paper Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-020-01518-2↗
- Paper Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. DOI 10.1186/s12885-018-5074-2↗
- Paper Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. DOI 10.1053/j.gastro.2018.05.041↗
- Kavita B. Mallya · 2 shared papers, 2021–2022 · strength 0.24
- Paper Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. DOI 10.1038/s41388-021-02047-2↗
- Paper Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-020-01518-2↗
- Nicholas J Caldwell · 1 shared paper, 2026 · strength 0.22
- Mingjuan Lisa Zhang · 1 shared paper, 2026 · strength 0.22
- Mari A. Mino-Kenudson · 1 shared paper, 2026 · strength 0.22
- Brian Matthew Wolpin · 1 shared paper, 2026 · strength 0.22
- Jonathan Andrew Nowak · 1 shared paper, 2026 · strength 0.22
- Tyler Jacks · 1 shared paper, 2026 · strength 0.22
- Rohitesh Gupta · 2 shared papers, 2020–2021 · strength 0.20
- Dipakkumar R. Prajapati · 2 shared papers, 2020–2021 · strength 0.20
- Harshabad Singh · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.